| Sheryse Desiree Mobley, DPM | |
|
5955 Zeamer Ave Elmendorf Afb, Anchorage, AK 99506 | |
| (907) 580-2778 | |
| Not Available |
| Full Name | Sheryse Desiree Mobley |
|---|---|
| Gender | Female |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 5955 Zeamer Ave Elmendorf Afb, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003470485 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 4434 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sheryse Desiree Mobley, DPM 1608 Joy Dr, Killeen, TX 76543-5069 Ph: () - | Sheryse Desiree Mobley, DPM 5955 Zeamer Ave Elmendorf Afb, Anchorage, AK 99506 Ph: (907) 580-2778 |
News Archive
The authors note that there is a consensus "that the current shortage of primary care physicians will worsen over the next ten years as the nation's population grows and ages and as insurance coverage expands as a result of the Affordable Care Act." They examine whether workplace changes will impact that assessment.
Compugen Ltd. today announced it has raised gross proceeds of $20 million, completing in full its previously announced Controlled Equity Offering facility. Under this facility, a total of approximately 4.1 million ordinary shares were sold at a weighted average price of approximately $4.91 per share. These shares were sold in the open market at prevailing prices during the period November 13, 2009 to December 29, 2009.
Researchers have revealed the molecular pathway that is affected during the onset of schizophrenia and successfully alleviated symptoms of the illness in mice, using a commonly used cancer drug.
As part of the American Recovery and Reinvestment Act of 2009, the government is investing billions of dollars to encourage health care providers to use electronic health record systems. Many providers will probably switch from older systems to new systems to qualify for the federal incentives, but whether the upgrade improves patient care and safety has remained an open question.
The Norwegian pharmaceutical company Lytix Biopharma AS today announced approvals from the Norwegian Medicines Agency ("Statens legemiddelverk") and the Swedish Medical Products Agency ("Läkemedelverket") to commence Phase I clinical trials of OncoporeTM (LTX-315) for the treatment of cancer.
› Verified 2 days ago
Anchorage Foot And Ankle Clinic, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 1000 E Dimond Blvd, Suite 201, Anchorage, AK 99515 Phone: 907-344-2155 Fax: 907-344-8841 | |
Dr. Jennifer Jansma, DPM Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 4100 Lake Otis Pkwy Ste 312, Anchorage, AK 99508 Phone: 907-569-3668 Fax: 907-569-3669 | |
Alaska Foot & Ankle Specialists Podiatrist Medicare: Medicare Enrolled Practice Location: 4100 Lake Otis Pkwy, Suite 312, Anchorage, AK 99508 Phone: 907-569-3668 Fax: 907-569-3669 | |
Dr. Jared Kern, DPM Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 4100 Lake Otis Pkwy, Suite 312, Anchorage, AK 99508 Phone: 907-569-3668 Fax: 907-569-3669 | |
Dr. Karl Albert Boesenberg, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2741 Debarr Rd, Suite C-315, Anchorage, AK 99508 Phone: 907-562-4958 Fax: 907-562-5195 | |
Dr. Christopher Scott Jetter, DPM Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 2250 E 42nd Ave, Anchorage, AK 99508 Phone: 907-569-3668 |